Logo-jrip
Submitted: 14 Jun 2019
Accepted: 23 Aug 2019
ePublished: 10 Sep 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2019;8(4): 289-291.
doi: 10.15171/jrip.2019.53

Scopus ID: 85076267169
  Abstract View: 2642
  PDF Download: 1066

Original Article

Serum interleukin-18 in children with steroid sensitive nephrotic syndrome

Sahar Sadr Moharrerpour 1 ORCID logo, Azar Nickavar 2* ORCID logo, Simin Sadeghi Bojd 3 ORCID logo, Sara Makhtomi 4 ORCID logo, Hossein Ghorbani 5 ORCID logo

1 Non-communicable Pediatric Disease Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
2 Pediatric Neprology Department, Iran University of Medical Sciences, Tehran, Iran
3 Pediatric Neprology Department, Zahedan University Medical Sciences, Zahedan, Iran
4 Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran
5 Pathology Department, Babol University of Medical Sciences, Babol, Iran
*Corresponding Author: Email: anickavar@yahoo.com

Abstract

Introduction: Idiopathic nephrotic syndrome has been considered a cell-mediated immunity disorder with T cell dysfunction.

Objectives: The purpose of this study was to investigate immunologic dysfunction in children with steroid-sensitive nephrotic syndrome (SSNS) by evaluating serum interleukin-18 (IL-18).

Patients and Methods: A total of 30 children with SSNS (n=20 males, n=10 females), aged 1–11 years were enrolled in this study. All of them were treated with steroids at the time of study. Serum IL-18 was compared during both active and remission phases of nephrotic syndrome. In addition, correlation between serum IL-18 with urine protein and serum biochemical variables was evaluated.

Results: Mean serum IL-18 was higher in the active phase, and decreased significantly poststeroid treatment (4.87±1.43 ng/L versus 2.39± 0.94 ng/L; P=0.01). It had no correlation with other variables.

Conclusion: According to increased serum IL-18 level, dysregulation of type-1 and type-2 mediated immune reactions is suggested in children with SSNS. 


Implication for health policy/practice/research/medical education:

The role of cell mediated immunity dysfunction has been widely postulated in pathogenesis of idiopathic nephrotic syndrome. IL-18 is a proinflammatory cytokine with important regulatory effect on immune response. Identification the pathogenic effect of IL-18 in children with nephrotic syndrome is important for further diagnostic evaluations and medical management in these patients, which is discussed in this article.

Please cite this paper as: Sadr Moharerpour S, Nickavar A, Sadeghi Bojd S, Makhtomi S, Ghorbani H. Serum interleukin-18 in children with steroid sensitive nephrotic syndrome. J Renal Inj Prev. 2019; 8(4):289-291. DOI: 10.15171/jrip.2019.53.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 2643

Your browser does not support the canvas element.


PDF Download: 1066

Your browser does not support the canvas element.